IACS-13909

BridgeBio's Navire preps SHP2 blocker for lung cancer trial after positive mouse study
Fierce Biotech
Mon, 09/14/20 - 10:14 am
Bridge Bio
Navire Pharma
lung cancer
clinical trials
IACS-13909